Overview

Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery

Status:
Terminated
Trial end date:
2020-01-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if Tranexamic Acid can safely reduce bleeding in people undergoing spinal fusion surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Exela Pharma Sciences, LLC.
Collaborator:
Spinemark Corporation Inc.
Treatments:
Tranexamic Acid